Charles Elias Assmann

Dr. Charles Elias Assmann

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Chemosphere
Verified
Journal Article
Closed access
GWGrazielle Castagna Cezimbra Weis
Grazielle Castagna Cezimbra Weis
CACharles Elias Assmann
Charles Elias Assmann
VMVitor Bastianello Mostardeiro
Vitor Bastianello Mostardeiro
AAAudrei de Oliveira Alves
Audrei de Oliveira Alves
JRJéssica Righi da Rosa
Jéssica Righi da Rosa
ICIjoni Hilda Costabeber
Ijoni Hilda Costabeber

1 July 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
CACharles Elias Assmann
Charles Elias Assmann
FCFrancine Carla Cadoná
Francine Carla Cadoná
BBBeatriz da Silva Rosa Bonadiman
Beatriz da Silva Rosa Bonadiman
EDEduardo Bortoluzzi Dornelles
Eduardo Bortoluzzi Dornelles
GTGabriela Trevisan
Gabriela Trevisan
ICIvana Beatrice Beatrice Mânica Mânica Da Cruz
Ivana Beatrice Beatrice Mânica Mânica Da Cruz

6 March 2022 in Journal of Molecular Medicine
Verified
Journal Article
Closed access
PDF file
GSGilnei Bruno da Silva
Gilnei Bruno da Silva
DMDaiane Manica
Daiane Manica
ASAlana Patrícia da Silva
Alana Patrícia da Silva
GKGreicy Cristine Kosvoski
Greicy Cristine Kosvoski
MHMarceli Cleunice Hanauer
Marceli Cleunice Hanauer
MBMARGARETE DULCE BAGATINI
MARGARETE DULCE BAGATINI

1 October 2019 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Closed access
GWGrazielle Castagna Cezimbra Weis
Grazielle Castagna Cezimbra Weis
CACharles Elias Assmann
Charles Elias Assmann
FCFrancine Carla Cadoná
Francine Carla Cadoná
BBBeatriz da Silva Rosa Bonadiman
Beatriz da Silva Rosa Bonadiman
AAAudrei de Oliveira Alves
Audrei de Oliveira Alves
ICIjoni Hilda Costabeber
Ijoni Hilda Costabeber

12 July 2016 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
FCFrancine Carla Cadoná
Francine Carla Cadoná
AMAlencar Kolinski Machado
Alencar Kolinski Machado
VAVerônica Farina Azzolin
Verônica Farina Azzolin
FBFernanda Barbisan
Fernanda Barbisan
EDEduardo Bortoluzzi Dornelles
Eduardo Bortoluzzi Dornelles
ICIvana Beatrice Beatrice Mânica Mânica Da Cruz
Ivana Beatrice Beatrice Mânica Mânica Da Cruz
We investigated the in vitro effects of guaraná and its main metabolites (caffeine, theobromine and catechin) on cytotoxicity and cell proliferation on colorectal cancer (CRC) line HT-29 cells and on oxaliplatin sensitivity. The cells were exposed to different concentrations of guaraná extract with and without oxaliplatin. The concentrations of bioactive molecules were also estimated considering their potential proportion on guaraná hydro-alcoholic extract. Apoptosis effect was analyzed by annexin V quantification using flow cytometry, while apoptosis pathway gene modulation (p53, Bax/Bcl-2 genes ratio, caspases 8 and 3) was determined by qRT-PCR analysis. Cells exposed to guaraná at a concentration of 100 μg/mL presented a similar cytotoxic effect as HT-29 cells treated with oxaliplatin and did not affect the sensitivity of the drug. Guaraná presented cell anti-proliferative effect and increased anti-proliferative oxaliplatin sensitivity at all concentrations tested here. Guaraná was able to induce apoptosis and up-regulate the p53 and Bax/Bcl-2 genes.

21 December 2015 in Neurotoxicity Research
Verified
Journal Article
Closed access
PDF file
CPCarla Roberta Nunes Polachini
Carla Roberta Nunes Polachini
RSRoselia Maria Spanevello
Roselia Maria Spanevello
DZDaniela Zanini
Daniela Zanini
JBJucimara Baldissarelli
Jucimara Baldissarelli
LPLuciane Belmonte Pereira
Luciane Belmonte Pereira
VMVera Maria Melchiors Morsch
Vera Maria Melchiors Morsch